Literature DB >> 28931472

Pharmaceutical cocrystals, salts and polymorphs: Advanced characterization techniques.

Edyta Pindelska1, Agnieszka Sokal1, Waclaw Kolodziejski2.   

Abstract

The main goal of a novel drug development is to obtain it with optimal physiochemical, pharmaceutical and biological properties. Pharmaceutical companies and scientists modify active pharmaceutical ingredients (APIs), which often are cocrystals, salts or carefully selected polymorphs, to improve the properties of a parent drug. To find the best form of a drug, various advanced characterization methods should be used. In this review, we have described such analytical methods, dedicated to solid drug forms. Thus, diffraction, spectroscopic, thermal and also pharmaceutical characterization methods are discussed. They all are necessary to study a solid API in its intrinsic complexity from bulk down to the molecular level, gain information on its structure, properties, purity and possible transformations, and make the characterization efficient, comprehensive and complete. Furthermore, these methods can be used to monitor and investigate physical processes, involved in the drug development, in situ and in real time. The main aim of this paper is to gather information on the current advancements in the analytical methods and highlight their pharmaceutical relevance.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Active pharmaceutical ingredient; Crystallographic studies; Drug; NMR crystallography; Solubility; Spectroscopic characterization; Stability; Thermal analysis

Mesh:

Substances:

Year:  2017        PMID: 28931472     DOI: 10.1016/j.addr.2017.09.014

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  14 in total

1.  Assembling the Puzzle of Taxifolin Polymorphism.

Authors:  Roman P Terekhov; Irina A Selivanova; Nonna A Tyukavkina; Igor R Ilyasov; Anastasiya K Zhevlakova; Alexander V Dzuban; Anatoliy G Bogdanov; Georgiy N Davidovich; Gennadii V Shylov; Andrey N Utenishev; Dmitriy Yu Kovalev; Anatoliy A Fenin; Tatyana G Kabluchko
Journal:  Molecules       Date:  2020-11-20       Impact factor: 4.411

Review 2.  Current and potential applications of simultaneous DSC-FTIR microspectroscopy for pharmaceutical analysis.

Authors:  Shan-Yang Lin
Journal:  J Food Drug Anal       Date:  2021-06-15       Impact factor: 6.157

3.  Ultrafast 1H MAS NMR Crystallography for Natural Abundance Pharmaceutical Compounds.

Authors:  Jochem Struppe; Caitlin M Quinn; Sucharita Sarkar; Angela M Gronenborn; Tatyana Polenova
Journal:  Mol Pharm       Date:  2020-01-13       Impact factor: 4.939

4.  Superior Dissolution Behavior and Bioavailability of Pharmaceutical Cocrystals and Recent Regulatory Issues.

Authors:  Meng Y Xia; Bing Q Zhu; Jian-R Wang; Ze E Yang; Xue F Mei
Journal:  ACS Med Chem Lett       Date:  2021-12-30       Impact factor: 4.345

Review 5.  Mechanochemistry: A Green Approach in the Preparation of Pharmaceutical Cocrystals.

Authors:  Mizraín Solares-Briones; Guadalupe Coyote-Dotor; José C Páez-Franco; Miriam R Zermeño-Ortega; Carmen Myriam de la O Contreras; Daniel Canseco-González; Alcives Avila-Sorrosa; David Morales-Morales; Juan M Germán-Acacio
Journal:  Pharmaceutics       Date:  2021-05-25       Impact factor: 6.321

6.  Synergy of Solid-State NMR, Single-Crystal X-ray Diffraction, and Crystal Structure Prediction Methods: A Case Study of Teriflunomide (TFM).

Authors:  Tomasz Pawlak; Isaac Sudgen; Grzegorz Bujacz; Dinu Iuga; Steven P Brown; Marek J Potrzebowski
Journal:  Cryst Growth Des       Date:  2021-05-10       Impact factor: 4.076

Review 7.  Mesoporous Silica Particles as Drug Delivery Systems-The State of the Art in Loading Methods and the Recent Progress in Analytical Techniques for Monitoring These Processes.

Authors:  Katarzyna Trzeciak; Agata Chotera-Ouda; Irena I Bak-Sypien; Marek J Potrzebowski
Journal:  Pharmaceutics       Date:  2021-06-24       Impact factor: 6.321

Review 8.  Pharmaceutical Cocrystals: New Solid Phase Modification Approaches for the Formulation of APIs.

Authors:  Anna Karagianni; Maria Malamatari; Kyriakos Kachrimanis
Journal:  Pharmaceutics       Date:  2018-01-25       Impact factor: 6.321

Review 9.  A Review about Regulatory Status and Recent Patents of Pharmaceutical Co-Crystals.

Authors:  Arun Kumar; Sandeep Kumar; Arun Nanda
Journal:  Adv Pharm Bull       Date:  2018-08-29

10.  Co-crystals, Salts or Mixtures of Both? The Case of Tenofovir Alafenamide Fumarates.

Authors:  Hannes Lengauer; Damjan Makuc; Damjan Šterk; Franc Perdih; Arthur Pichler; Tina Trdan Lušin; Janez Plavec; Zdenko Časar
Journal:  Pharmaceutics       Date:  2020-04-10       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.